| | Dependent | Model 1 | Model 2 | Model 3 | Model 4 | | Coefficient (95% CI) | Coefficient (95% CI) | Coefficient (95% CI) | Coefficient (95% CI) |
| | SRP | | | | | | Nasal | −1.786 (−2.097, −0.600) | −1.285 (−2.266, −0.303) | −1.274 (−2.270, −0.279) | −0.868 (−1.877, 0.140) | | Temporal | −1.018 (−1.871, −0.166) | −0.725 (−1.622, 0.171) | −0.667 (−1.573, 0.240) | −0.277 (−1.191, 0.637) | | Superior | −1.023 (−1.952, 0.093) | −0.777 (−1.766, 0.213) | −0.788 (−1.802, 0.226) | −0.305 (−1.315, 0.705) | | Inferior | −1.669 (−2.799, −0.559) | −1.226 (−2.397, −0.058) | −1.198 (−2.387, 0.010) | −0.754 (−1.967, 0.459) | | Fovea | −0.019 (−1.150, 1.188) | −0.004 (−1.172, 1.162) | 0.216 (−1.120, 1.293) | 0.285 (−1.531, 0.962) | | FAZ | −0.011 (−0.042, 0.020) | −0.006 (−0.029, 0.018) | −0.078 (−0.031, 0.015) | 0.285 (−0.018, 0.028) |
| | DRP | | | | | | Nasal | −1.348 (−2.097, 0.600) | −1.043 (−1.817, −0.269) | −1.024 (−1.797, 0.252) | −1.029 (−1.847, −0.211) | | Temporal | −0.958 (−1.871, −0.166) | −0.716 (−1.448, 0.015) | −0.640 (−1.352, 0.071) | −0.474 (−1.217, 0.269) | | Superior | −0.726 (−1.859, −1.750) | −0.624 (−2.309, 1.061) | −0.598 (−2.330, 1.134) | −0.377 (−2.204, 1.450) | | Inferior | −1.556 (−2.372, 0.741) | −1.161 (−1.989, −0.333) | −1.125 (−1.969, 0.281) | −0.746 (−1.592, 0.101) | | Fovea | 0.281 (−1.12, 1.682) | 0.323 (−1.190, 1.836) | 0.005 (−1.331, 1.763) | −0.434 (−1.997, 1.130) |
|
|
Model 1, crude; model 2, adjustment for age and gender; model 3, further adjustment for intraocular pressure, cup-to-disc ratio, and retinal nerve fiber layer thickness; model 4, further adjustment for axial length. β-PPA, β-peripapillary atrophy; DRP, deep retinal plexus; SRP, superficial retinal plexus.
|
